Page 11 - Chief Development News Today

Charlie Clark Nissan El Paso and Charlie Clark INFINITI will be presenting a check to El Pasoans Fighting Hunger on Thursday following the conclusion of its Fig

The expected opening date of two big names joining the Oracle has been revealed.

Mundipharma today announced rezafungin (rezafungin acetate) has been approved in the European Union (EU) for the treatment of invasive candidiasis in adults. The approval by the European Commission (EC) follows the positive opinion of the Committee...

Accomplished renewables development executive to advance Urban Grid’s 12 GW solar and 7 GW storage pipeline and lead market expansion for the company....

Dermata Enrolls First Patient in Pivotal DMT310 Phase 3 STAR-1 Clinical ...

- About 550 patients will be treated once weekly for 12 weeks -- STAR-1 topline results expected in first quarter of 2025 -- Acne affects about 50 million patients in the U.S. -SAN DIEGO, CA / ACCESSWIRE / December 20, 2023 / Dermata Therapeutics, Inc. (Nasdaq:DRMA, DRMAW) ("Dermata" or the "Company&q...

Hemisphere Energy Corporation is pleased to announce the appointment of Ashley Ramsden-Wood as Chief Development Officer. Ms. Ramsden-Wood has served as Vice President of Engineering at Hemisphere...

- VRDN-003 clinical data exceeded expectations with extended half-life of 40-50 days, 4-5x longer than VRDN-001, supporting a potential best-in-class, low-volume, less frequent, self-administered...

Vancouver, British Columbia--(Newsfile Corp. - December 18, 2023) - Hemisphere Energy Corporation (TSXV: HME) (OTCQX: HMENF) (Hemisphere